3D Printed Drugs Market Product Overview to 2031

3D Printed Drugs Market 2023 : 3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. 

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for 3D Printed Drugs estimated at US$ 239.5 million in the year 2022, is projected to reach a revised size of US$ 297.8 million by 2028, growing at a CAGR of 3.7% during the forecast period 2022-2028.

Spritam is the only 3D printed drug which has received FDA approval. This drug was first available in the market in 2016, and can be used to treat epilepsy. 

Top Key Players:

• Aprecia Pharmaceuticals
• GlaxoSmithKline
• Revolution Medicines
• FabRX

3D Printed Drugs Market By Applications

• Children
• Elderly
• Others

3D Printed Drugs Market By Types

• Spritam
• Others

Get a Sample PDF of report –https://www.360researchreports.com/enquiry/request-sample/21657438

Aerospace Raw Materials Market Growth and Forecast till 2031

Laser Soldering Machine Market Growth and Forecast till 2031

Railway Shock Absorbers Market Growth and Forecast till 2031

Cable Modem Subscribers Market Growth and Forecast till 2031

Luxury Electric Vehicle Market Growth and Forecast till 2031

Purified Human Proteins Market Growth and Forecast till 2031

Amifampridine Phosphate Market Growth and Forecast till 2031

Eye Tracking AR Glasses Market Growth and Forecast till 2031

Scaffolding Accessories Market Growth and Forecast till 2031

Urothelial Cancer Drugs Market Growth and Forecast till 2031